BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/25/2025 4:19:26 PM | Browse: 373 | Download: 1002
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 104253
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Study
Article Title Detecting plasma SHOX2, HOXA9, SEPTIN9, and RASSF1A methylation and circulating cancer cells for cholangiocarcinoma clinical diagnosis and monitoring
Manuscript Source Unsolicited Manuscript
All Author List Jing Yu, Qiu-Chen Liu, Shuang-Yan Lu, Shun Wang and Hua Zhang
ORCID
Author(s) ORCID Number
Jing Yu http://orcid.org/0000-0001-5836-5334
Shun Wang http://orcid.org/0000-0003-2192-730X
Funding Agency and Grant Number
Funding Agency Grant Number
Medical Talents of Wuhan Health and Family Planning Commission 2017[51]
Medical Talents of Wuhan Hospital of Traditional Chinese and Western Medicine
Hubei Natural Science Foundation 2023AFB1091
Wuhan Medical Research Project WX23A36
Corresponding Author Shun Wang, Department of Laboratory, Wuhan Chinese and Western Medicine Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 215 Zhongshan Road, Wuhan 430022, Hubei Province, China. wang_shun6688@sina.com
Key Words Cholangiocarcinoma; Methylation; Circulating cancer cells; Diagnosis; Prognosis
Core Tip This study first analyzed the clinical diagnosis and monitoring value of detecting plasma SHOX2, HOXA9, SEPTIN9, and RASSF1A methylation for cholangiocarcinoma (CCA). We determined that the four DNA plasma methylations exhibited 64.58% sensitivity and 94% specificity for detecting CCA. The hazard ratio of prognosis for the risk of CCA risk was identified using the Circulating tumor cells (CTCs) count, tumor stage, methylation, and carbohydrate antigen 19-9 (CA199) levels as independent prognostic factors. We developed a predictive nomogram for CCA overall survival, age, stage, CTCs, methylation, and CA199, with a C-index of 0.705 (95%CI: 0.605-0.805). This model evaluates risk factors.
Publish Date 2025-03-25 16:19
Citation

Yu J, Liu QC, Lu SY, Wang S, Zhang H. Detecting plasma SHOX2, HOXA9, SEPTIN9, and RASSF1A methylation and circulating cancer cells for cholangiocarcinoma clinical diagnosis and monitoring. World J Gastrointest Oncol 2025; 17(4): 104253

URL https://www.wjgnet.com/1948-5204/full/v17/i4/104253.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i4.104253
Full Article (PDF) WJGO-17-104253-with-cover.pdf